EXACT SCIENCES CORP (EXAS) Asset Writedowns and Impairment (2020 - 2025)

Exact Sciences (EXAS) has reported Asset Writedowns and Impairment for 6 consecutive years, with $406000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment fell 99.95% year-over-year to $406000.0; the TTM figure through Dec 2025 stood at $7.2 million (down 99.17% YoY), while the FY2025 annual figure was $7.2 million, down 99.17% from the prior year.
• Asset Writedowns and Impairment retreated to $406000.0 in Q4 2025 per EXAS's latest filing, from $543000.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $838.2 million in Q4 2024 and bottomed at $10000.0 in Q4 2021.
• Historically, Asset Writedowns and Impairment has averaged $65.2 million across 5 years, with a median of $5.3 million in 2024.
• Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment surged 68080.0% — and 2025, when it tumbled 99.95%.
• Exact Sciences' Asset Writedowns and Impairment stood at $10000.0 in 2021, then soared by 68080.0% to $6.8 million in 2022, then tumbled by 91.9% to $552000.0 in 2023, then jumped by 151741.3% to $838.2 million in 2024, then sank by 99.95% to $406000.0 in 2025.
• Business Quant data shows EXAS's Asset Writedowns and Impairment at $406000.0 in Q4 2025, $543000.0 in Q3 2025, and $6.3 million in Q1 2025.